Common for patients to undergo multiple cardiac imaging tests, with high cumulative radi... (involving ionizing radiation undergone b...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> MEDICINE >> NEWS

Common for patients to undergo multiple cardiac imaging tests, with high cumulative radiation dose

Date:11/15/2010

involving ionizing radiation undergone beginning October 1988, and all subsequent procedures through June 2008, at the center.

Patients underwent a median (midpoint) of 15 procedures involving radiation exposure, of which 4 were high-dose procedures, defined as an effective dose of at least 3 mSv (millisievert; a measure of radiation dose), the equivalent of 1 year's natural background radiation. A total of 200 patients (18.2 percent) had at least 3 MPIs and 4.9 percent had at least 5 MPI examinations.

The researchers found that the median cumulative estimated effective dose from MPI alone was 28.9 mSv, and for all medical testing, was 64.0 mSv. A total of 71 patients (6.5 percent) received cumulative doses of more than 100 mSv due to MPI alone, and 31.4 percent of patients received more than 100 mSv from all medical sources, including 120 patients (10.9 percent) who received cumulative dose of more than 200 mSv.

The primary reason for testing was chest pain, breathing difficulty, or both in 66.8 percent of examinations. More than 80 percent of initial and 90 percent of repeat MPI examinations were performed in patients with known cardiac disease or symptoms consistent with it. Of 1,097 patients undergoing index MPI, 38.6 percent underwent additional MPI studies. For this group of patients undergoing multiple MPIs, the median cumulative estimated effective dose was 121 mSv.

Patients undergoing multiple MPI examinations were significantly more likely to be older and male. Men and white patients had higher cumulative estimated effective doses.

"Our study reveals very high cumulative estimated effective doses to many patients undergoing MPI, and especially to patients undergoing repeat MPI testing. More than 30 percent of patients received a cumulative estimated effective dose of more than 100 mSv, a level at which there is little controversy over the potential for increased cancer risks," the authors write. "Efforts are n
'/>"/>

Contact: Alex Lyda
alyda@columbia.edu
212-305-0820
JAMA and Archives Journals
Source:Eurekalert

0

GOOD

Page: 1 2 3
Related medicine news :

1. Common Eye Condition Linked to Elevated Eye Pressure
2. Brain bleeding is common with aging, UCI study finds
3. Common Foot Disorders Can Be Inherited, Research Shows
4. Exercise May Help Beat the Common Cold
5. Common stomach bacteria may fight off inflammatory bowel disease caused by Salmonella
6. Knowledge gaps, fears common among parents of children with drug-resistant bacteria
7. Common anxiety disorders make it tougher to quit cigarettes
8. A redeeming role for a common virus
9. Considerable proportion of patients with advanced cancer continue to undergo common cancer screening
10. Physical symptoms common, disabling among patients with cancer and pain or depression
11. Vitamin D-ficiency common among orthopaedic surgery

Post Your Comments:

(Date:5/18/2013)... few extra cups of coffee each month might help ... as primary sclerosing cholangitis (PSC), a new study suggests. ... found that drinking coffee was associated with a reduced ... cirrhosis of the liver, liver failure and biliary cancer. ... "While rare, PSC has extremely detrimental effects," ...

(Date:5/18/2013)... 18, 2013) There are significant cost and ... to diagnose or treat gastrointestinal problems, according to ... , A study by New York Presbyterian Hospital ... testing may substantially reduce the cost and risk ... is believed to affect nearly 25 percent of ...

(Date:5/18/2013)... 2013 Assisted living and retirement ... safety and comfort of their residents. Systems Technologies ... with an effective and cost-efficient solution – VisionLink ... integrated, turnkey communications solution that helps nurses provide ... independence and privacy. , The VisionLink ...

(Date:5/18/2013)... 2013 Transvaginal mesh lawsuits ... move forward in a consolidated litigation underway in New ... According to a notice on the Court’s website, the ... litigation will be held on Wednesday, May 22nd. ... in the proceeding on behalf of women who suffered ...

(Date:5/18/2013)... The “World Healthcare IT Market: Trends & Forecast (2010 ... restraints, and opportunities in North America, Europe, Asia, & ... 89 market data tables , ... , http://www.marketsandmarkets.com/Market-Reports/healthcare-information-technology-market-136.html , Early buyers ... healthcare IT market is expected to grow from $99.6 ...

Breaking Medicine News(10 mins):Health News:Study Links Coffee to Lower Risk for Rare Liver Disease 2 Health News:New research identifies practice changes to improve value and quality of GI procedures 2 Health News:VisionLink Nurse Call System's New Features Serve the Unique Needs of Retirement Communities 2 Health News:VisionLink Nurse Call System's New Features Serve the Unique Needs of Retirement Communities 3 Health News:Transvaginal Mesh Lawsuits: Bernstein Liebhard LLP Notes Upcoming Case Management Conference in New Jersey Ethicon Pelvic Mesh Litigation 2 Health News:Transvaginal Mesh Lawsuits: Bernstein Liebhard LLP Notes Upcoming Case Management Conference in New Jersey Ethicon Pelvic Mesh Litigation 3 Health News:Healthcare IT Market to reach US$ 162.2 Billion by 2015 at a CAGR of 10.2% - New Report by MarketandMarkets 2 Health News:Healthcare IT Market to reach US$ 162.2 Billion by 2015 at a CAGR of 10.2% - New Report by MarketandMarkets 3

[0] Study Links Coffee to Lower Risk for Rare Liver Disease [0] New research identifies practice changes to improve value and quality of GI procedures [0] VisionLink Nurse Call System's New Features Serve the Unique Needs of Retirement Communities [0] Transvaginal Mesh Lawsuits: Bernstein Liebhard LLP Notes Upcoming Case Management Conference in New Jersey Ethicon Pelvic Mesh Litigation [0] Healthcare IT Market to reach US$ 162.2 Billion by 2015 at a CAGR of 10.2% - New Report by MarketandMarkets

... the form of percutaneous coronary intervention (PCI) is now ... infarction. New European guidelines issued in November 2008 emphasised ... to restore blood flow to the heart and improve ... in patients with stable coronary artery disease; PCI has ...

... Construction Company, the nation,s leading builder of healthcare facilities, ... proceed with the $42 million Phase Two expansion to ... start in March 2009 with completion scheduled for March ... plant, emergency rooms, ICU, CCU, three operating rooms and ...

... PARK, Ill., Feb. 6 Abbott ( NYSE: ABT ... Antitrust,Improvements Act of 1976 (HSR) applicable to Abbott,s cash ... common stock of Advanced Medical,Optics (AMO) expired last night ... The expiration of the HSR waiting period satisfies ...

... of 7 HIV+ Patients Receiving Dapsone Therapy at Significant ... IRVINE, Calif., Feb. 6 Masimo (Nasdaq: ... Motion and Low-Perfusion pulse oximetry, today announced that a ... Medicine 38th Critical Care Congress suggests providers should consider ...

... revenues increase by 35% over same period in ... are in Canadian dollars unless otherwise noted),BELLEVILLE, ON, ... (TSX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, ... of its 2009 fiscal year, ending December 31, ...

... a new study shows that losing weight is perhaps the ... disorders, according to a new study in the American ... the American Thoracic Society,s three peer-reviewed journals. , Weight ... fancy high-tech treatment, but it is an exciting therapy for ...

Efficacy of stents is improved when their placement is determined by arterial blood flow measurement Turner to Manage Construction of $42 Million Expansion of Northern Inyo Hospital in Bishop, Calif.Abbott Acquisition of Advanced Medical Optics Clears U.S. Antitrust Review New Clinical Study Presented at the Society for Critical Care Medicine Shows Value of Pulse CO-Oximetry(TM) to Identify Acquired Methemoglobinemia Bioniche Reports Fiscal 2009 Second Quarter Losing weight can cure obstructive sleep apnea in overweight patients

(Date:5/17/2013)... BEIJING , May 17, 2013 Sinovac Biotech ... vaccines in China , today announced that ... quarter ended March 31, 2013, before market on Tuesday, May ... Tuesday, May 28, 2013, at 8:00 a.m. EDT (May 28, ... Company,s financial results and provide an update on recent corporate ...

(Date:5/16/2013)... ZURICH , May 17, 2013 ... and Research (A*STAR) and Switzerland,s Cytos ... been dosed in a Phase 1 clinical trial with their ... virus-like particle (VLP) technology. In this first Phase 1 clinical ... and its potential to protect against H1N1 influenza infection will ...

(Date:5/16/2013)... 16, 2013 PTC Therapeutics, Inc., today announced that ... with the U.S. Securities and Exchange Commission ("SEC") relating ... stock. The number of shares to be offered and ... determined. (Logo: http://photos.prnewswire.com/prnh/20010919/PTCLOGO ) ... joint book-running managers for the offering. Cowen and Company ...

Breaking Medicine Technology:Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 2 Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 3 A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 2 A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 3 A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 4 A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 5 A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 6 PTC Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering 2

[0] Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results [0] A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing [0] PTC Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering

... 14, 2011 Naviscan, Inc., the worldwide leader in ... Cheng MD, PhD has joined the Naviscan Board of ... business experience related to reimbursement in the medical device ... Affairs and Reimbursement at Acclarent, Inc. After acquisition by ...

... Codexis, Inc. (Nasdaq: CDXS ) today announced the ... Technology Leadership Forum, to be held in Vail, CO on ... Financial Officer, will appear on a panel titled "Crude Alternatives: ... 8 at 12:30 p.m. ET. A webcast is not being ...

Cached Medicine Technology:Naviscan Further Strengthens its Board of Directors With the Addition of Dr. Andre Cheng 2

Naviscan Further Strengthens its Board of Directors With the Addition of Dr. Andre Cheng Codexis to Present at the Pacific Crest and Canaccord Genuity Conferences

... Plate Capability The Equalizer 384 includes ... and equal tip spacing, choice of two software ... addition, this model allows you to evenly space ... accessing many gels and for use with 384 ...

... Expandable Tip System A lower cost alternative ... to perform multi-sample transfers between two different vessel ... knob, tip spacing can be quickly and easily ... 96 well plates. Ergonomic Design for Unparalleled ...

... A lower cost alternative to Equalizers, the patented ... between two different vessel configurations. With the push ... be quickly and easily adjusted for test tubes ... Ergonomic Design for Unparalleled Comfort Pick one ...

Medicine Products:

Impact Equalizer 384 8-Channel Electronic Pipettor, 1-30l Impact2 EXP 8-Channel Electronic Pipettor, 15-1250L Impact EXP 8-Channel Electronic Pipettor, 0.5-12.5L Impact2 EXP 6-Channel Electronic Pipettor, 15-1250L